Commonwealth Equity Services
HUMA icon

Commonwealth Equity Services’s Humacyte HUMA Stock Holding History

Commonwealth Equity Services’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4K Sell
13,330
-2,869
-18% -$2.66K ﹤0.01% 4399
2026
Q1 		$9.83K Buy
16,199
+195
+1% +$203 ﹤0.01% 4281
2025
Q4 		$15.4K Sell
16,004
-3,653
-19% -$5.17K ﹤0.01% 4253
2025
Q3 		$34K Sell
19,657
-29,054
-60% -$56.9K ﹤0.01% 4185
2025
Q2 		$102K Sell
48,711
-45,125
-48% -$86.7K ﹤0.01% 4063
2025
Q1 		$160K Buy
93,836
+10,708
+13% +$40.2K ﹤0.01% 3898
2024
Q4 		$420K Buy
83,128
+17,665
+27% +$87.4K ﹤0.01% 3111
2024
Q3 		$356K Buy
65,463
+36,347
+125% +$240K ﹤0.01% 3201
2024
Q2 		$140K Sell
29,116
-12,743
-30% -$66.3K ﹤0.01% 3751
2024
Q1 		$130K Buy
41,859
+9,279
+28% +$31.2K ﹤0.01% 3752
2023
Q4 		$93K Buy
32,580
+20,000
+159% +$51.3K ﹤0.01% 3684
2023
Q3 		$37K Buy
+12,580
New +$41.6K ﹤0.01% 3686

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Commonwealth Equity Services's HUMA Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Humacyte (HUMA) stake by 18% in Q2 2026, selling an estimated $2.66K and leaving 13,330 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4399.

Commonwealth Equity Services first reported a position in HUMA in Q3 2023 and has held it in 12 quarters since. The position peaked at $420K in Q4 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Commonwealth Equity Services held 13,330 shares of Humacyte worth $10.4K as of Q2 2026.
  • Commonwealth Equity Services sold 2,869 Humacyte shares in Q2 2026, an estimated $2.66K.
  • Humacyte made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4399 holding.
  • Commonwealth Equity Services first reported a position in Humacyte in Q3 2023 and has held it in 12 quarters since.
  • Commonwealth Equity Services's Humacyte position peaked at $420K in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.